

Estée Lauder Companies vs Constellation Brands
Global luxury beauty company selling makeup and skincare vs Major North American producer of premium alcoholic beverages. Which is the better buy for your portfolio in August 2026? Plain-English answer below.
Estee Lauder built its empire on prestige beauty brands sold through department stores and travel retail, while Constellation Brands distributes premium beer, wine, and spirits through U.S. wholesale channels, putting two consumer companies with pricing power in front of very different post-pandemic demand dynamics. Both rely on brand investment and channel relationships to sustain premium price points. Estee Lauder Companies vs Constellation Brands tracks revenue recovery, channel mix shifts, and which management team is more effectively navigating its sector's unique headwinds.
Estee Lauder built its empire on prestige beauty brands sold through department stores and travel retail, while Constellation Brands distributes premium beer, wine, and spirits through U.S. wholesale ...
Why It’s Moving

Estee Lauder is drawing cautious analyst support as incremental target hikes keep recovery hopes alive.
- Analysts remain divided on Estee Lauder, with the broader consensus still landing in the buy/overweight range, suggesting investors see recovery potential but not a clean breakout yet.
- Recent target updates have been incremental rather than dramatic, including UBS lifting its view slightly to $86 and keeping a neutral stance, which points to cautious optimism rather than a strong re-rating.
- The stock is still trading below the typical analyst target range, so the market is weighing whether improving expectations for margins and demand can close that gap.

STZ is moving as analysts stay upbeat and the market re-prices its longer-term earnings outlook.
- Analysts remain broadly constructive on Constellation Brands, with consensus estimates still clustering around a positive outlook even as individual target prices vary.
- Recent target updates from major firms have stayed supportive, suggesting investors are focusing on resilient demand and margin execution rather than short-term noise.
- The stock’s move appears tied more to shifting analyst expectations than to a fresh company-specific catalyst in the past week, keeping attention on how the market weighs beverage sector trends.

Estee Lauder is drawing cautious analyst support as incremental target hikes keep recovery hopes alive.
- Analysts remain divided on Estee Lauder, with the broader consensus still landing in the buy/overweight range, suggesting investors see recovery potential but not a clean breakout yet.
- Recent target updates have been incremental rather than dramatic, including UBS lifting its view slightly to $86 and keeping a neutral stance, which points to cautious optimism rather than a strong re-rating.
- The stock is still trading below the typical analyst target range, so the market is weighing whether improving expectations for margins and demand can close that gap.

STZ is moving as analysts stay upbeat and the market re-prices its longer-term earnings outlook.
- Analysts remain broadly constructive on Constellation Brands, with consensus estimates still clustering around a positive outlook even as individual target prices vary.
- Recent target updates from major firms have stayed supportive, suggesting investors are focusing on resilient demand and margin execution rather than short-term noise.
- The stock’s move appears tied more to shifting analyst expectations than to a fresh company-specific catalyst in the past week, keeping attention on how the market weighs beverage sector trends.
Investment Analysis
Pros
- Estée Lauder reported Q4 EPS above expectations, showing resilience in a challenging prestige beauty market.
- The company expanded gross margins by 230 basis points, reflecting improved cost management and operational efficiency.
- China sales are stabilising with signs of market share gains, offering potential for future revenue recovery.
Considerations
- Organic sales declined by 8% for the full fiscal year, indicating persistent demand headwinds in key markets.
- Operating margin contracted by 220 basis points, highlighting ongoing profitability pressures despite margin improvements.
- Stock price remains volatile, with recent declines despite earnings beats, reflecting investor concerns over growth prospects.
Pros
- Constellation Brands benefits from exclusive US rights to high-growth Mexican beer brands like Corona and Modelo.
- The company operates with best-of-breed margins and is well-positioned to capitalise on strong secular beverage trends.
- Shares trade at a notable discount to fair value estimates, suggesting potential upside for value-oriented investors.
Considerations
- Recent quarterly EPS declined by 16%, reflecting short-term profitability challenges in the beverage segment.
- The business faces evolving industry dynamics, including shifting consumer preferences and competitive pressures.
- Exposure to regulatory and macroeconomic risks in the alcohol sector could impact future growth and margins.
Estée Lauder Companies (EL) Next Earnings Date
The next earnings date for EL is August 19, 2026, before the market opens. The upcoming report is expected to cover Q4 fiscal 2026 results. This date is consistent across multiple earnings calendars and the company’s investor events schedule.
Constellation Brands (STZ) Next Earnings Date
The next earnings date for STZ is expected to be October 5, 2026, based on the company’s recent reporting schedule. This report should cover fiscal Q2 2027. If the date changes, it will usually be announced closer to the release window.
Estée Lauder Companies (EL) Next Earnings Date
The next earnings date for EL is August 19, 2026, before the market opens. The upcoming report is expected to cover Q4 fiscal 2026 results. This date is consistent across multiple earnings calendars and the company’s investor events schedule.
Constellation Brands (STZ) Next Earnings Date
The next earnings date for STZ is expected to be October 5, 2026, based on the company’s recent reporting schedule. This report should cover fiscal Q2 2027. If the date changes, it will usually be announced closer to the release window.
Buy EL or STZ in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


